Drug Shortages and Otolaryngology.
advocacy
chemotherapy
clinical ethics
drug shortages
public health
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
05 Sep 2023
05 Sep 2023
Historique:
received:
11
08
2023
accepted:
12
08
2023
medline:
5
9
2023
pubmed:
5
9
2023
entrez:
5
9
2023
Statut:
aheadofprint
Résumé
Every year in the United States, hundreds of shortages of life-saving, essential drugs impact patients and health care workers. While otolaryngologists may be shielded from these relative to other specialties, there is still a significant clinical impact with potentially dangerous consequences. Shortages of local anesthetics lead to increased costs, labor demands, and risk of medical errors. Shortages of cisplatin and carboplatin, workhorses in head and neck oncology, may leave patients without proven alternative therapies. The economic and geopolitical challenges that provoke these shortages are well described. So too are potential solutions at the national, regional, and local levels. Otolaryngologists have a responsibility to contribute to coordinated responses to drug shortages to protect and advocate for their current and future patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.
Références
Poulsen JH, Rishøj RM, Fischer H, et al. Drug change: “a hassle like no other”. An in-depth investigation using the Danish patient safety database and focus group interviews with Danish hospital personnel. Ther Adv Drug Saf. 2019;10:204209861985999. doi:10.1177/2042098619859995
Noguchi Y. Some cancer drugs are in short supply, putting patients' care at risk. Here's why. June 15, 2023. Accessed July 17, 2023. https://www.npr.org/sections/health-shots/2023/06/15/1181876655/cancer-drugs-cisplatin-carboplatin-shortage
Committee on Homeland Security & Governmental Affairs. Peters, Stabenow & Slotkin call on FDA to take all possible actions to mitigate cancer drug shortages. May 25, 2023. Accessed July 17, 2023. https://www.hsgac.senate.gov/media/dems/peters-stabenow-slotkin-call-on-fda-to-take-all-possible-actions-to-mitigate-cancer-drug-shortages/
American Society of Health-System Pharmacists. Drug Shortages List. 2023. Accessed July 17, 2023. https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortages-List
US Food and Drug Administration. The Drug Shortages Task Force. Drug shortages: root causes and potential solutions. 2019. Accessed July 12, 2023. https://www.fda.gov/media/131130/download
Hernandez I, Hershey TB, Donohue JM. Drug shortages in the United States: are some prices too low. JAMA. 2020;323(9):819-820. doi:10.1001/jama.2019.20504
Chen E, Goold S, Harrison S, et al. Drug shortage management: a qualitative assessment of a collaborative approach. PLoS One. 2021;16(4):e0243870. doi:10.1371/journal.pone.0243870
Shuman AG, Fox E, Unguru Y. Preparing for COVID-19-related drug shortages. Ann Am Thorac Soc. 2020;17(8):928-931. doi:10.1513/AnnalsATS.202004-362VP
Vizient Newsroom. New Vizient Survey finds drug shortages cost hospitals just under $360M annually in labor expenses. June 26, 2019. Accessed July 17, 2023. http://newsroom.vizientinc.com/en-US/releases/new-vizient-survey-finds-drug-shortages-cost-hospitals-just-under-360m-annually-in-labor-expenses
United States Senate Committee on Homeland Security and Governmental Affairs. Short supply: the health and national security risks of drug shortages. 2023. Accessed July 12, 2023. https://www.hsgac.senate.gov/wp-content/uploads/2023-03-20-HSGAC-Majority-Draft-Drug-Shortages-Report.pdf
Wosińska ME, Frank RG. Federal policies to address persistent generic drug shortages. The Hamilton Project. June 2023. Accessed July 14, 2023. https://www.brookings.edu/wp-content/uploads/2023/06/20230621_ES_THP_GSI_Report_Final.pdf